API
< Back to all clusters
[HEALTH] · United States · 6 sources

started · updated

Study finds hormone therapy does not increase heart disease risk in women

A large-scale study involving more than 52,000 women suggests that modern hormone therapy for menopause does not increase the risk of heart attacks, strokes, blood clots, or early death. Researchers tracked women between the ages of 45 and 59 for an average of 12 years, with some participants followed for up to 23 years.

The study compared women using hormone therapy in the form of pills, patches, or gels against those who did not. Results showed that 4.4 percent of women receiving hormone therapy experienced cardiovascular events, compared to 4.6 percent of those who did not. Mortality rates before age 80 were also similar, at 1.3 percent for users and 1.2 percent for non-users.

Lead researcher Ronen Arbel noted that concerns regarding heart health are a primary reason women avoid menopause symptom management. The findings align with previous actions by the U.S. Food and Drug Administration, which removed certain warnings from hormone products after finding no link to increased risks of heart disease, breast cancer, or dementia.

Entities

American College of Obstetricians and Gynecologists · Ronen Arbel · U.S. Food and Drug Administration